rs149302006

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002968.3(SALL1):​c.3794G>A​(p.Gly1265Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0015 in 1,614,066 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 4 hom. )

Consequence

SALL1
NM_002968.3 missense

Scores

7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.96

Publications

11 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007502228).
BP6
Variant 16-51137293-C-T is Benign according to our data. Variant chr16-51137293-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 288122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00124 (189/152174) while in subpopulation NFE AF = 0.00179 (122/68008). AF 95% confidence interval is 0.00153. There are 0 homozygotes in GnomAd4. There are 85 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 189 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SALL1NM_002968.3 linkc.3794G>A p.Gly1265Glu missense_variant Exon 3 of 3 ENST00000251020.9 NP_002959.2 Q9NSC2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SALL1ENST00000251020.9 linkc.3794G>A p.Gly1265Glu missense_variant Exon 3 of 3 1 NM_002968.3 ENSP00000251020.4 Q9NSC2-1

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
189
AN:
152056
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000624
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00145
AC:
365
AN:
251494
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.00427
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.00202
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00153
AC:
2234
AN:
1461892
Hom.:
4
Cov.:
37
AF XY:
0.00152
AC XY:
1108
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.00157
AC:
70
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00379
AC:
99
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000916
AC:
79
AN:
86258
European-Finnish (FIN)
AF:
0.000262
AC:
14
AN:
53420
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5768
European-Non Finnish (NFE)
AF:
0.00164
AC:
1827
AN:
1112012
Other (OTH)
AF:
0.00172
AC:
104
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
141
281
422
562
703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00124
AC:
189
AN:
152174
Hom.:
0
Cov.:
31
AF XY:
0.00114
AC XY:
85
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.000434
AC:
18
AN:
41516
American (AMR)
AF:
0.00144
AC:
22
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4804
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10606
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00179
AC:
122
AN:
68008
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00159
Hom.:
0
Bravo
AF:
0.00136
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00145
AC:
176
EpiCase
AF:
0.00267
EpiControl
AF:
0.00350

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SALL1: BP4, BS1, BS2 -

Townes-Brocks syndrome 1 Benign:2
May 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 10, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SALL1-related disorder Benign:1
Apr 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Townes syndrome Benign:1
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
.;T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.71
T;T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.0075
T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Uncertain
2.4
.;M
PhyloP100
3.0
PROVEAN
Benign
-0.81
N;N
REVEL
Benign
0.27
Sift
Uncertain
0.015
D;D
Sift4G
Benign
0.096
T;T
Polyphen
1.0
.;D
Vest4
0.18
MVP
0.29
MPC
0.28
ClinPred
0.029
T
GERP RS
5.5
Varity_R
0.35
gMVP
0.50
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149302006; hg19: chr16-51171204; API